Cofoe Medical Technology Co.,Ltd. (SHE:301087)

Market Cap	10.88B +51.1%
Revenue (ttm)	3.39B +13.6%
Net Income	371.61M +19.2%
EPS	1.81 +19.9%
Shares Out	203.20M
PE Ratio	29.59
Forward PE	24.23
Dividend	1.80 (3.24%)
Ex-Dividend Date	Apr 10, 2026

Volume	2,512,772
Average Volume	2,863,923
Open	53.54
Previous Close	53.55
Day's Range	53.00 - 55.18
52-Week Range	31.87 - 63.99
Beta	0.93
RSI	42.47
Earnings Date	Apr 30, 2026

About Cofoe Medical Technology

Cofoe Medical Technology Co.,Ltd. engages in the research and development, production, sales, and service of medical devices in China. The company offers diagnosis and respires products, including blood pressure monitors, thermometers, nebulizers, oxygen concentrators, fingertip pulse oximeters, fetal doppler, and CPAP and BPAP devices; and in vitro diagnostic products, such as glucose meter, HCG test kits, H.Pylori, UTM, DNA/RNA extraction reagents, and respiratory tract infections. It also provides wheelchair, commode chair, hospital beds, ai...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 5,081
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301087

Financial Performance

In 2025, Cofoe Medical Technology's revenue was 3.39 billion, an increase of 13.56% compared to the previous year's 2.98 billion. Earnings were 371.61 million, an increase of 19.20%.